Anti-Mouse CD18 [Clone M18/2] — Purified in vivo PLATINUM™ Functional Grade

Anti-Mouse CD18 [Clone M18/2] — Purified in vivo PLATINUM™ Functional Grade

Product No.: C2516

- -
- -
Clone
M18/2
Target
CD18
Formats AvailableView All
Product Type
Hybridoma Monoclonal Antibody
Alternate Names
Integrin β2, β2 integrin, ITGB2
Isotype
Rat IgG2a κ
Applications
FC
,
IHC
,
IP
,
WB
,
Block
,
Stimulation

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Rat
Recommended Dilution Buffer
Immunogen
Mouse CTL glycoprotein
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
<0.5 EU/mg as determined by the LAL method
Purity
≥98% monomer by analytical SEC
>95% by SDS Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
State of Matter
Liquid
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Pathogen Testing
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2-8° C Wet Ice
Applications and Recommended Usage?
Quality Tested by Leinco
WB
Additional Applications Reported In Literature ?
Block
FC
IHC
IP
Stim
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
M18/2 activity is directed against mouse CD18.
Background
Integrins are a large family of α/β heterodimeric transmembrane molecules that mediate adhesion, migration, cell survival, and cell differentiation1. The leukocytic cell-adhesion molecule (Leu-CAM) family has three members, LFA-1 (CD18/CD11a), CR3 (also known as MAC-1) (CD18/CD11b), and p150,95 (CD18/CD11c), all of which share the β chain CD182. Depending on which molecule CD18 is bound to, this β chain plays important roles in inflammation, initiation of the immune response, phagocytosis, adherence to endothelium, chemotaxis, and can act as a fibrinogen receptor as part of its heterodimer3.

M18/2 was generated by immunizing rat with mouse cytotoxic T cell glycoproteins and fusing the spleen cells with mouse myeloma line P3X63Ag8.6534. M18/2 was selected by immunoprecipitation of LFA-1 and found to bind to the β chain of both LFA-1 and MAC-1. M18/2 has subsequently been used to study lymphoma metastasis3,5, myelin phagocytosis6, platelet caspases and thrombocytosis7, and the immunosuppression of corneal allografts8.

Antigen Distribution
CD18 is expressed on all leukocytes as well as on myeloid cells.
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-3 (CD50), iC3b, fibrinogen
NCBI Gene Bank ID
UniProt.org
Research Area
Cell Adhesion
.
Cell Biology
.
Immunology
.
Innate Immunity

References & Citations

1 Luo BH, Carman CV, Springer TA. Annu Rev Immunol. 25:619-647. 2007.
2 Sanchez-Madrid F, Nagy JA, Robbins E, et al. J Exp Med. 158(6):1785-1803. 1983.
3 Driessens MH, van Hulten P, Zuurbier A, et al. J Leukoc Biol. 60(6):758-765. 1996.
4 Sanchez-Madrid F, Simon P, Thompson S, et al. J Exp Med. 158(2):586-602. 1983.
5 Zahalka MA, Okon E, Naor D. J Immunol. 150(10):4466-4477. 1993.
6 Reichert F, Rotshenker S. Neurobiol Dis. 12(1):65-72. 2003.
7 Piguet PF, Vesin C. Eur J Haematol. 68(5):253-261. 2002.
8 Hori J, Isobe M, Yamagami S, et al. Exp Eye Res. 65(1):89-98. 1997.
Flow Cytometry
IHC
Immunoprecipitation Protocol
General Western Blot Protocol
Block
Stimulation

Certificate of Analysis

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.